PRTG — Portage Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Portage Biotech, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2.77	23.4	10.5	5.03	1.67
Net Total Accounts Receivable
Net Total Receivables	0.683	0.351	0.801	0.103	0.08
Prepaid Expenses
Total Current Assets	4.95	24.8	13.7	7.7	2.23
Net Property, Plant And Equipment	—	—	—	0.035	0
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	175	195	99.1	7.78	2.23
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.21	0.783	1.86	2.88	1.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	73.4	73.5	23.1	3.76	2.35
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	101	121	76	4.02	-0.123
Total Liabilities & Shareholders' Equity	175	195	99.1	7.78	2.23
Total Common Shares Outstanding